Slideshow
-
Acalabrutinib_Slide01
-
Acalabrutinib_Slide02
-
Acalabrutinib_Slide03
-
Acalabrutinib_Slide04
-
Acalabrutinib_Slide05
-
Acalabrutinib_Slide06
-
Acalabrutinib_Slide07
-
Acalabrutinib_Slide08
-
Acalabrutinib_Slide09
-
Acalabrutinib_Slide10
-
Acalabrutinib_Slide11
-
Acalabrutinib_Slide12
-
Acalabrutinib_Slide13
-
Acalabrutinib_Slide14
-
Acalabrutinib_Slide15
-
Acalabrutinib_Slide16
-
Acalabrutinib_Slide17
-
Acalabrutinib_Slide18
-
Acalabrutinib_Slide19
-
Acalabrutinib_Slide20
-
Acalabrutinib_Slide21
-
Acalabrutinib_Slide22
-
Acalabrutinib_Slide23
This slideshow reviews acalabrutinib (Calquence), indicated for the treatment of myelodysplastic syndrome (MDS).
Table of Contents
Slide 4: Dosage and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 17: What to Tell Your Patient
Slide 23: Reference